Novo Nordisk Inks A $2.1 Billion Deal To Develop Next Generation Obesity Pills

The Danish drugmaker is collaborating with Vivtex, cofounded by billionaire Robert Langer, to quickly iterate oral versions of successors to Ozempic and Wegovy.
By Published On: Febbraio 25, 2026Categories: DesignCommenti disabilitati su Novo Nordisk Inks A $2.1 Billion Deal To Develop Next Generation Obesity Pills

Share This Story, Choose Your Platform!

About the author : admin